Parikh A - Search Results

1

Population Pharmacokinetics of Epcoritamab Following Subcutaneous Administration in Relapsed or Refractory B Cell Non-Hodgkin Lymphoma.

Li T, Gibiansky L, Parikh A, van der Linden M, Sanghavi K, Putnins M, Sacchi M, Feng H, Ahmadi T, Gupta M, Xu S. Li T, et al. Among authors: parikh a. Clin Pharmacokinet. 2024 Dec 21. doi: 10.1007/s40262-024-01464-2. Online ahead of print. Clin Pharmacokinet. 2024. PMID: 39708278

2

Industry Perspective on Standardizing Food-Effect Studies for New Drug Development.

Marroum PJ, Nuthalapati S, Parikh A, Shebley M, Hoffman D, Zha J, Khatri A, Awni WM. Marroum PJ, et al. Among authors: parikh a. Clin Pharmacokinet. 2018 Aug;57(8):901-909. doi: 10.1007/s40262-018-0630-0. Clin Pharmacokinet. 2018. PMID: 29460023 Review.

3

Assessment of Clinical Drug-Drug Interactions of Elagolix, a Gonadotropin-Releasing Hormone Receptor Antagonist.

Polepally AR, Ng JW, Salem AH, Dufek MB, Parikh A, Carter DC, Kamradt K, Mostafa NM, Shebley M. Polepally AR, et al. Among authors: parikh a. J Clin Pharmacol. 2020 Dec;60(12):1606-1616. doi: 10.1002/jcph.1689. Epub 2020 Jul 7. J Clin Pharmacol. 2020. PMID: 33045114 Free PMC article. Clinical Trial.

4

Exposure-response evaluations of venetoclax efficacy and safety in patients with non-Hodgkin lymphoma.

Parikh A, Gopalakrishnan S, Freise KJ, Verdugo ME, Menon RM, Mensing S, Salem AH. Parikh A, et al. Leuk Lymphoma. 2018 Apr;59(4):871-879. doi: 10.1080/10428194.2017.1361024. Epub 2017 Aug 10. Leuk Lymphoma. 2018. PMID: 28797193 Clinical Trial.

5

Are Clinical Therapeutic Protein-Drug Interaction Studies Needed When Disease Modification Is Driving the Potential Interaction?

Pang Y, Rosebraugh MR, Freise KJ, Parikh A, Mohamed MF. Pang Y, et al. Among authors: parikh a. J Clin Pharmacol. 2018 Oct;58(10):1371-1372. doi: 10.1002/jcph.1290. Epub 2018 Aug 21. J Clin Pharmacol. 2018. PMID: 30129669 No abstract available.

6

Effect of co-medications on paritaprevir, ritonavir, ombitasvir, dasabuvir and ribavirin pharmacokinetics: analysis of data from seven Phase II/III trials.

Polepally AR, Badri PS, Parikh A, Rodrigues L Jr, Da Silva-Tillmann BA, Mensing S, Podsadecki TJ, Awni WM, Dutta S, Menon RM. Polepally AR, et al. Among authors: parikh a. Antivir Ther. 2016;21(8):707-714. doi: 10.3851/IMP3079. Epub 2016 Sep 1. Antivir Ther. 2016. PMID: 27584548

7

Phase I Study of 2- or 3-Week Dosing of Telisotuzumab Vedotin, an Antibody-Drug Conjugate Targeting c-Met, Monotherapy in Patients with Advanced Non-Small Cell Lung Carcinoma.

Camidge DR, Morgensztern D, Heist RS, Barve M, Vokes E, Goldman JW, Hong DS, Bauer TM, Strickler JH, Angevin E, Motwani M, Parikh A, Sun Z, Bach BA, Wu J, Komarnitsky PB, Kelly K. Camidge DR, et al. Among authors: parikh a. Clin Cancer Res. 2021 Nov 1;27(21):5781-5792. doi: 10.1158/1078-0432.CCR-21-0765. Epub 2021 Aug 23. Clin Cancer Res. 2021. PMID: 34426443 Free PMC article. Clinical Trial.

8

Phase 1 study of telisotuzumab vedotin in Japanese patients with advanced solid tumors.

Fujiwara Y, Kenmotsu H, Yamamoto N, Shimizu T, Yonemori K, Ocampo C, Parikh A, Okubo S, Fukasawa K, Murakami H. Fujiwara Y, et al. Among authors: parikh a. Cancer Med. 2021 Apr;10(7):2350-2358. doi: 10.1002/cam4.3815. Epub 2021 Mar 6. Cancer Med. 2021. PMID: 33675179 Free PMC article. Clinical Trial.

9

Model Informed Dosing Regimen and Phase I Results of the Anti-PD-1 Antibody Budigalimab (ABBV-181).

Powderly J, Spira A, Kondo S, Doi T, Luke JJ, Rasco D, Gao B, Tanner M, Cassier PA, Gazzah A, Italiano A, Tosi D, Afar DE, Parikh A, Engelhardt B, Englert S, Lambert SL, Kasichayanula S, Mensing S, Menon R, Vosganian G, Tolcher A. Powderly J, et al. Among authors: parikh a. Clin Transl Sci. 2021 Jan;14(1):277-287. doi: 10.1111/cts.12855. Epub 2020 Dec 26. Clin Transl Sci. 2021. PMID: 32770720 Free PMC article. Clinical Trial.

10

Pharmacokinetics of Tacrolimus and Cyclosporine in Liver Transplant Recipients Receiving 3 Direct-Acting Antivirals as Treatment for Hepatitis C Infection.

Badri PS, Parikh A, Coakley EP, Ding B, Awni WM, Dutta S, Menon RM. Badri PS, et al. Among authors: parikh a. Ther Drug Monit. 2016 Oct;38(5):640-5. doi: 10.1097/FTD.0000000000000315. Ther Drug Monit. 2016. PMID: 27310199 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,117 results

Search Page

Filters